Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intratumoral TriMix Injections in Early Breast Cancer Patients (TMBA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03788083
Recruitment Status : Recruiting
First Posted : December 27, 2018
Last Update Posted : March 15, 2019
Sponsor:
Collaborator:
eTheRNA immunotherapies
Information provided by (Responsible Party):
Universitair Ziekenhuis Brussel

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2020
Estimated Study Completion Date : December 30, 2020